Gotham Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,478
| Closed | -$349K | – | 1484 |
|
|
2024
Q1 | $349K | Hold |
7,478
| – | – | 0.01% | 1153 |
|
|
2023
Q4 | $358K | Buy |
+7,478
| New | +$358K | 0.01% | 1087 |
|
|
2023
Q3 | – | Sell |
-15,822
| Closed | -$730K | – | 1400 |
|
|
2023
Q2 | $730K | Sell |
15,822
-3,039
| -16% | -$140K | 0.02% | 859 |
|
|
2023
Q1 | $756K | Buy |
18,861
+9,779
| +108% | +$392K | 0.02% | 830 |
|
|
2022
Q4 | $421K | Buy |
9,082
+3,176
| +54% | +$147K | 0.01% | 942 |
|
|
2022
Q3 | $245K | Buy |
+5,906
| New | +$245K | 0.01% | 1031 |
|
|
2021
Q1 | – | Sell |
-1,546
| Closed | -$214K | – | 1072 |
|
|
2020
Q4 | $214K | Buy |
+1,546
| New | +$214K | 0.01% | 918 |
|
|
2019
Q2 | – | Sell |
-4,562
| Closed | -$316K | – | 1258 |
|
|
2019
Q1 | $316K | Buy |
+4,562
| New | +$316K | ﹤0.01% | 982 |
|